This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Marfan syndrome | |
|---|---|
| Name | Marfan syndrome |
| Field | Cardiology, Medical genetics, Orthopedics, Ophthalmology |
Marfan syndrome is a heritable connective tissue disorder that affects the cardiovascular, skeletal, and ocular systems and predisposes to life‑threatening aortic pathology. Clinical management intersects cardiology, medical genetics, and ophthalmology and involves multidisciplinary teams from tertiary centers to community hospitals. Landmark figures in genetic medicine, major medical centers, and patient advocacy organizations have shaped contemporary diagnostic criteria and therapeutic strategies.
Cardiovascular features commonly include aortic root dilatation, aortic aneurysm, aortic dissection, and mitral valve prolapse; these findings are central to recommendations from major centers such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Royal Brompton Hospital. Skeletal manifestations include tall stature, arachnodactyly, pectus excavatum, pectus carinatum, scoliosis, and joint hypermobility; these are evaluated by specialists at institutions like Great Ormond Street Hospital, Boston Children's Hospital, St Thomas' Hospital, Guy's Hospital, and Evelina London Children's Hospital. Ocular signs include ectopia lentis, myopia, and early cataract formation, often managed at centers such as Bascom Palmer Eye Institute, Wills Eye Hospital, Moorfields Eye Hospital, University College Hospital, and Scheie Eye Institute. Additional features can involve dural ectasia, pneumothorax, and skin striae; patients may be referred to orthopedics departments at Hospital for Special Surgery, Royal National Orthopaedic Hospital, Addenbrooke's Hospital, Toronto General Hospital, and Charité – Universitätsmedizin Berlin. Multispecialty clinics coordinate care with input from genetics services at institutions like Stanford Health Care, UCSF Medical Center, Yale New Haven Hospital, Mount Sinai Hospital (New York), and Karolinska University Hospital.
Marfan syndrome arises from pathogenic variants in the fibrillin‑1 gene, FBN1, which encodes an extracellular matrix glycoprotein essential for elastic fiber formation—discoveries that involved research groups at University of Texas Southwestern Medical Center, Columbia University, Harvard Medical School, University of Cambridge, and Institut Pasteur. The molecular cascade affects transforming growth factor beta signaling pathways implicated by laboratories at Cold Spring Harbor Laboratory, Salk Institute, Max Planck Institute for Heart and Lung Research, Weizmann Institute of Science, and National Institutes of Health. FBN1 mutations include missense, nonsense, and frameshift changes with variable expressivity noted in family studies reported from Johns Hopkins University, UCL Great Ormond Street Institute of Child Health, University of Zurich, Karolinska Institutet, and McGill University. Autosomal dominant inheritance with variable penetrance necessitates genetic counseling by teams at Genetics Centre, Guy's and St Thomas' NHS Foundation Trust, American College of Medical Genetics and Genomics, British Society for Genetic Medicine, European Society of Human Genetics, and Clinical Genetics Society. Rare phenotypic overlap with disorders linked to FBN1‑related loci has been investigated at Imperial College London, Mayo Clinic Arizona, University of Toronto, Vanderbilt University Medical Center, and University of Melbourne.
Diagnostic evaluation integrates clinical criteria, imaging, and molecular testing in pathways endorsed by professional bodies such as American Heart Association, European Society of Cardiology, American College of Cardiology, British Cardiac Society, and Society for Cardiovascular Magnetic Resonance. Echocardiography, CT, and MRI are key modalities provided by radiology departments at Memorial Sloan Kettering Cancer Center (cardiac imaging labs), Royal Marsden Hospital, Karolinska University Hospital Radiology, Addenbrooke's Hospital Radiology, and Seattle Children's Hospital. Ophthalmologic assessment performed at Massachusetts Eye and Ear, Johns Hopkins Wilmer Eye Institute, Royal Victorian Eye and Ear Hospital, Beaumont Hospital (Dublin), and Singapore National Eye Centre can reveal lens subluxation. Genetic testing with next‑generation sequencing panels and variant interpretation is available through laboratories affiliated with Broad Institute, Ambry Genetics, Invitae, GeneDx, and Mayo Clinic Laboratories. Differential diagnosis includes conditions evaluated by teams at Great Ormond Street Hospital and Royal Free Hospital for connective tissue disorders such as Loeys‑Dietz syndrome and homocystinuria.
Medical therapy emphasizes blood pressure control and reduction of aortic wall stress using beta‑blockers, angiotensin receptor blockers, and other antihypertensive agents prescribed in clinics at Cleveland Clinic, Mayo Clinic, UCSF Medical Center, Brigham and Women's Hospital, and Guy's and St Thomas' Hospital. Elective aortic root replacement and valve‑sparing procedures are performed by cardiac surgeons at Cleveland Clinic Heart and Vascular Institute, Mayo Clinic Cardiovascular Surgery, Mount Sinai Heart, Royal Papworth Hospital, and University Hospital Zurich. Endovascular and open repair for distal aortic disease involve teams at St Bartholomew's Hospital, Toronto General Hospital, Royal Infirmary of Edinburgh, Charité – Universitätsmedizin Berlin, and Hôpital Européen Georges‑Pompidou. Ophthalmic interventions—lensectomy, intraocular lens implantation, and retinal procedures—are offered at Bascom Palmer Eye Institute, Wills Eye Hospital, Moorfields Eye Hospital, Scheie Eye Institute, and Johns Hopkins Wilmer Eye Institute. Scoliosis management and chest wall correction are directed by orthopedic units at Hospital for Special Surgery, Royal National Orthopaedic Hospital, Shriners Hospitals for Children, Texas Scottish Rite Hospital for Children, and Royal Children's Hospital (Melbourne). Multidisciplinary surveillance protocols are supported by patient registries and guidelines from European Reference Network on Rare Multisystemic Vascular Diseases, National Marfan Foundation, Marfan Europe, American Academy of Pediatrics, and American College of Medical Genetics and Genomics.
Prognosis has improved with earlier diagnosis and elective surgical repair; long‑term outcomes published from cohorts at Mayo Clinic, Cleveland Clinic, Erasmus MC, Ghent University Hospital, and University of Leuven show reduced aortic mortality. Life‑limiting complications include aortic dissection, heart failure, prosthetic valve complications, pulmonary complications such as pneumothorax, and retinal detachment; these are managed across tertiary centers including Royal Brompton Hospital, Royal Papworth Hospital, Mount Sinai Hospital (New York), Addenbrooke's Hospital, and Hospital de la Santa Creu i Sant Pau. Reproductive counseling and pregnancy management are coordinated at maternal‑fetal medicine units at Johns Hopkins Hospital, Karolinska University Hospital, Queen Charlotte's and Chelsea Hospital, Sheffield Teaching Hospitals, and SingHealth Duke‑NUS.
Prevalence estimates—derived from population studies and registries maintained by institutions such as Centers for Disease Control and Prevention, National Institutes of Health, Public Health England, Agence nationale de santé publique (France), and Statens Serum Institut—suggest a worldwide prevalence of roughly 1 in 5,000 to 1 in 10,000 individuals. Geographic case series and genetic surveys have been reported from United States Department of Veterans Affairs Medical System hospitals, National Health Service (England) trusts, Rikshospitalet (Oslo), Hospital Clínic de Barcelona, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and All India Institute of Medical Sciences. Founder effects and population‑specific alleles have been studied in cohorts at University of Iceland, University of Tokyo, Seoul National University Hospital, University of Cape Town, and Pontificia Universidad Católica de Chile.
The eponym reflects early clinical description by Paediatricians and clinicians documented in 19th‑ and 20th‑century European and North American medical literature with historical analyses by historians affiliated to Wellcome Trust, Royal College of Physicians, Royal Society of Medicine, American Medical Association, and National Library of Medicine. Advocacy, awareness campaigns, and support networks are led by organizations including National Marfan Foundation, Marfan Foundation of Australia, Marfan Europe, Marfan Association (UK), and Rare Diseases UK, with fundraising events often involving hospitals such as Great Ormond Street Hospital and Royal Brompton Hospital. Research consortia, clinical trials, and registries have been coordinated by academic groups at European Society of Cardiology, American Heart Association, International Society for Heart and Lung Transplantation, European Reference Network, and ClinicalTrials.gov‑listed centers. Public figures and notable patients have drawn attention to the condition through media coverage managed by outlets such as BBC, The New York Times, The Guardian, Le Monde, and The Washington Post.
Category:Genetic disorders